The Evolving Landscape of AI Implementation in New Drug Discovery & Development

Name: The Evolving Landscape of AI Implementation in New Drug Discovery & Development
Start: 2022-02-16T11:00:00-05:00
End: 2022-02-16T12:30:00-05:00

16 February 2022 @ 11:00 am - 12:30 pm

FREE

CQDM is proud to present a new series of webinars: The Evolving Landscape of AI Implementation in New Drug Discovery & Development.

In the second event of the series Philip Tagari, VP of Research (Therapeutic Discovery), Amgen will host a panel of leading pharmaceutical and artificial intelligence executives to discuss the topic:

Generation of Innovative Therapeutics using Artificial Intelligence.

The majority of BIOTECanada’s over 200 member companies are small/medium sized, early-mid stage companies focused on the commercialization of an innovation.

Recognizing this, a core BIOTECanada strategic objective is to support member companies in successfully commercializing their business undertakings. In this context, BIOTECanada negotiates significant savings for member companies attending key industry investor/ partnering conferences including BIO, World Congress, Biotech Showcase and many others.

These offerings are designed to significantly reduce the cost of doing business for BIOTECanada members.

Click here to log in and visit the members only area

Access Codes

Don’t have access to the members only area?